Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07334366

Broccoli Sprout Extract for Cognitive Function

A 12-week Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Broccoli Sprout Extract on Cognitive Function Improvement in Adults With Mild Cognitive Impairment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Pusan National University Yangsan Hospital · Academic / Other
Sex
All
Age
50 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This clinical trial aims to determine whether broccoli sprout extract improves cognitive function in adults with mild cognitive impairment and to assess its safety. The main questions are: * Does broccoli sprout extract improve cognitive function in participants? * What side effects occur when participants take broccoli sprout extract?

Detailed description

Researchers will compare broccoli sprout extract to a placebo to evaluate their effectiveness in improving cognitive function in participants. Participants will: * Take dietary broccoli sprout extract or a placebo daily for 12 weeks. * Visit the clinic at screenig, 0, 6, and 12 weeks for checkups and tests

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBroccoli sprout extract (BSE)BSE 1,000 mg/day for 12 weeks
DIETARY_SUPPLEMENTPlacebo ControlPlacebo (crystalline cellulosel) 1,000 mg/day for 12 weeks

Timeline

Start date
2025-04-16
Primary completion
2026-12-30
Completion
2026-12-31
First posted
2026-01-12
Last updated
2026-01-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT07334366. Inclusion in this directory is not an endorsement.